3 completed, 3 recruiting, 2 not yet recruiting, 2 unknown. 11 Phase 2, 4 Phase 1, 2 Phase 3.
Follow Taurine: new trials by email Literature Review of Taurine trials Research Report on Taurine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 30 | 2026-12-30 | 2026-10-16 |
| Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma Taurine - Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC) | Phase 2 | Recruiting | Sun Yat-sen University | 130 | 2026-05-08 | 2026-10-30 |
| A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis DMTs + taurine, DMTs - Multiple Sclerosis (MS) Relapsing Remitting | Phase 2 | Not yet recruiting | Sichuan Academy of Medical Sciences | 80 | 2026-01-01 | 2025-12-04 |
| Taurine Supplementation in Long COVID Taurine, Placebo - Long COVID | Phase 2 / Phase 3 | Recruiting | University of Alberta | 300 | 2025-11-18 | 2026-09-18 |
| Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer Taurine, Sintilimab, XELOX regimen - Gastric Cancer | Phase 2 | Unknown | Tang-Du Hospital | 60 | 2023-08-01 | 2023-11-08 |
| Taurine Eye Drops May Prevent the Progression of Cataract Taurine - Cataract | Phase 1 / Phase 2 | Active not recruiting | University Of Anbar | 50 | 2023-07-10 | 2024-12-09 |
| Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes Active comparator Taurine, Placebo Comparator - Diabetes Mellitus, Type 2 | Phase 2 | Recruiting | Hospital de Clinicas de Porto Alegre | 94 | 2021-06-12 | 2026-09-24 |
| Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients Taurine - it is a Group of Metabolic Diseases in, Which a Person Has High Blood Sugar, Either | Phase 1 / Phase 2 | Unknown | Hamad Medical Corporation | 20 | 2012-11-01 | 2012-11-09 |
| Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine taurine - Homocystinuria | Phase 1 / Phase 2 | Completed | University of Colorado, Denver | 15 | 2010-01-01 | 2018-07-09 |
| A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment Taurine 4g - Psychotic Disorders | Phase 2 / Phase 3 | Completed | Melbourne Health | 121 | 2007-01-01 | 2015-11-20 |
| Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study taurine - Bipolar Disorder, Mania | Phase 2 | Completed | Mclean Hospital | 60 | 2005-04-01 | 2019-03-01 |
Post-Acute COVID-19 Syndrome (2) · Bipolar Disorder (1) · Cataract (1) · Depression (1) · Diabetes Mellitus, Type 2 (1) · Glucose Metabolism Disorders (1) · Homocystinuria (1) · Inflammation (1) · Mania (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Nasopharyngeal Carcinoma (1) · Psychotic Disorders (1) · Stomach Neoplasms (1) · Stomatitis (1)
University of Alberta (2) · Hamad Medical Corporation (1) · Hospital de Clinicas de Porto Alegre (1) · Mclean Hospital (1) · Melbourne Health (1) · Sichuan Academy of Medical Sciences (1) · Sun Yat-sen University (1) · Tang-Du Hospital (1) · University Of Anbar (1) · University of Colorado, Denver (1)
China (2) · United States (2) · Australia (1) · Brazil (1) · Canada (1) · Iraq (1)
Lawrence Richer, MD, MSc (2) · Beatriz D Schaan, PhD (1) · Beth L Murphy, MD, PhD (1) · Dr Colin P O'Donnell, MB,MRCPsych (1) · Johan VanHove, MD PhD MBA (1) · Jun Ma (1) · Xiaodi Zhao, MD, PhD (1) · Xin Wang, MD, PhD (1) · Yuanyuan Lu, MD, PhD (1)